posted on 2016-02-17, 10:58authored byB. Braithwaite, R. M. Greenhalgh, R. Grieve, T. B. Hassan, F. Moore, A. A. Nicholson, C. V. Soong, F. Heatley, A. Anjum, G. Kalinowska, M. Gomes, J. T. Powell, R. Hinchliffe, M. Sweeting, M. M. Thompson, S. G. Thompson, P. Ulug, I. Roberts, P. R. F. Bell, A. Cheetham, J. Stephany, C. Warlow, P. Lamont, J. Moss, J. Tijssen, M. Thompson, R. Ashleigh, L. Thompson, N. J. Cheshire, J. R. Boyle, F. Serracino-Inglott, R. J. Hinchliffe, R. Bell, N. Wilson, M. Bown, M. Dennis, Martin Davis, S. Howell, M. G. Wyatt, D. Valenti, P. Bachoo, P. Walker, S. MacSweeney, J. N. Davies, D. Rittoo, S. D. Parvin, W. Yusuf, C. Nice, I. Chetter, A. Howard, P. Chong, R. Bhat, D. McLain, A. Gordon, I. Lane, S. Hobbs, W. Pillay, T. Rowlands, A. El-Tahir, J. Asquith, S. Cavanagh, L. Dubois, T. L. Forbes, E. Ashworth, S. Baker, H. Barakat, C. Brady, Matthew James Brown, C. Bufton, T. Chance, A. Chrisopoulou, M. Cockell, A. Croucher, L. Dabee, N. Dewhirst, J. Evans, A. Gibson, S. Gorst, M. Gough, L. Graves, M. Griffin, J. Hatfield, F. Hogg, S. Howard, C. Hughes, D. Metcalfe, M. Lapworth, I. Massey, T. Novick, G. Owen, N. Parr, D. Pintar, S. Spencer, C. Thomson, O. Thunder, T. Wallace, S. Ward, V. Wealleans, L. Wilson, J. Woods, T. Zheng
Aims: To report the longer term outcomes following either a strategy of endovascular repair first or open repair of ruptured abdominal aortic aneurysm, which are necessary for both patient and clinical decision-making. Methods and results: This pragmatic multicentre (29 UK and 1 Canada) trial randomized 613 patients with a clinical diagnosis of ruptured aneurysm; 316 to an endovascular first strategy (if aortic morphology is suitable, open repair if not) and 297 to open repair. The principal 1-year outcome was mortality; secondary outcomes were re-interventions, hospital discharge, health-related quality-of-life (QoL) (EQ-5D), costs, Quality-Adjusted-Life-Years (QALYs), and cost-effectiveness [incremental net benefit (INB)]. At 1 year, all-cause mortality was 41.1% for the endovascular strategy group and 45.1% for the open repair group, odds ratio 0.85 [95% confidence interval (CI) 0.62, 1.17], P = 0.325, with similar re-intervention rates in each group. The endovascular strategy group and open repair groups had average total hospital stays of 17 and 26 days, respectively, P < 0.001. Patients surviving rupture had higher average EQ-5D utility scores in the endovascular strategy vs. open repair groups, mean differences 0.087 (95% CI 0.017, 0.158), 0.068 (95% CI-0.004, 0.140) at 3 and 12 months, respectively. There were indications that QALYs were higher and costs lower for the endovascular first strategy, combining to give an INB of £3877 (95% CI £253, £7408) or 4356 (95% CI 284, 8323). Conclusion: An endovascular first strategy for management of ruptured aneurysms does not offer a survival benefit over 1 year but offers patients faster discharge with better QoL and is cost-effective. Clinical trial registration ISRCTN 48334791.
History
Citation
European Heart Journal, 2015, 36 (31), pp. 2061-2069
Author affiliation
/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGY/School of Medicine/Department of Cardiovascular Sciences
Version
VoR (Version of Record)
Published in
European Heart Journal
Publisher
Oxford University Press (OUP) for European Society of Cardiology